Curis Lifesciences Ltd. IPO Details – Price, Date, GMP & Analysis
Curis Lifesciences Ltd. IPO Overview
Company Overview
Curis Lifesciences Limited, established in 2010, is a pharmaceutical company focused on developing, manufacturing, and distributing a wide range of products. It operates a modern manufacturing facility in Sanand, Gujarat, ensuring high-quality standards. The company serves over 100 corporate clients through contract manufacturing and has its own brand marketing in Yemen and Kenya. It offers various pharmaceutical formulations, including tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, Curis Lifesciences employs 93 permanent staff.
IPO Timeline
Opens
Nov 7
Closes
Nov 11
Allotment
Nov 12
Refunds
Nov 13
Shares Credit
Nov 13
Listing
Nov 14
Opens
Nov 7
Closes
Nov 11
Allotment
Nov 12
Refunds
Nov 13
Shares Credit
Nov 13
Listing
Nov 14
Subscription data will be available when the IPO opens for bidding.
Financial Information
Financial Data Table
Detailed breakdown of financial metrics across years
| Financial Metric | 2025 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Assets | ₹42.53 Cr | ₹42.53 Cr | ₹33.88 Cr | ₹29.75 Cr |
| EBITDA | ₹9.54 Cr | ₹9.54 Cr | ₹8.39 Cr | ₹3.28 Cr |
| NET Worth | ₹16.23 Cr | ₹16.23 Cr | ₹5.87 Cr | ₹1.01 Cr |
| Profit After Tax | ₹6.11 Cr | ₹6.11 Cr | ₹4.87 Cr | ₹1.88 Cr |
| Reserves and Surplus | ₹10.29 Cr | ₹10.29 Cr | ₹5.37 Cr | ₹0.51 Cr |
| Total Borrowing | ₹15.62 Cr | ₹15.62 Cr | ₹17.09 Cr | ₹16.19 Cr |
| Total Income | ₹49.65 Cr | ₹49.65 Cr | ₹35.87 Cr | ₹36.42 Cr |
Strengths & Risks Analysis
Strengths & Risks Analysis
Detailed strengths and risks analysis will be available when the company releases its prospectus and detailed documentation.
Read Company ProspectusIPO Details
Curis Lifesciences IPO Details
| Face Value | ₹10 per share |
| IPO Date | November 7, 2025 to November 11, 2025 |
| Issue Price Band | ₹120 to ₹128 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Listing Date | [.] |
| Lot Size | 1,000 Shares |
| Net Offered to Public | 20,42,000 shares (aggregating up to ₹26.14 Cr) |
| Reserved for Market Maker | 1,08,000 shares (aggregating up to ₹1.38 Cr)RS Wealth Management Private Limited |
| Sale Type | Fresh Capital |
| Share Holding Post Issue | 80,84,434 shares |
| Share Holding Pre Issue | 59,34,434 shares |
| Total Issue Size | 21,50,000 shares (aggregating up to ₹27.52 Cr) |
Curis Lifesciences IPO Reservation
Share Reservation Distribution
Curis Lifesciences IPO Promoter Holding
| Promoter Holding Post Issue | 68.03% |
| Promoter Holding Pre Issue | 92.68% |
Key Dates
